The Effect of Bicarbonate Supplementation on Performance and Gastrointestinal Symptoms in Rugby Players.
NCT ID: NCT07017582
Last Updated: 2025-06-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
17 participants
INTERVENTIONAL
2023-02-01
2023-02-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The participants were 17 elite rugby players. Half of the participants receive sodium bicarbonate (0.3 g/kg body weight), the other half receive a placebo (salt). Ingestion of the supplementation/placebo occured 90 minutes before high-intensity rugby-specific training Variables analysed were measure at baseline, prior to exercise, during exercise and after exercise.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Acute Sodium Bicarbonate Supplementation in Athletes
NCT03810404
Influence of Sodium Bicarbonate on Time-to-exhaustion at Critical Power in Endurance Athletes
NCT01621074
Effects of Sodium Bicarbonate on Endurance Performance
NCT07171047
Sodium Bicarbonate Supplementation in Athletes
NCT03165357
Effect of Sodium Bicarbonate on Exercise Performance
NCT06098794
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Bicarbonate
Supplementation with 0.3 g/kg of sodium bicarbonate
Soidum Bicarbonate
Supplementation with 0.03 g/kg of sodium bicarbonate
Placebo
Supplementation with placebo: 0.03 g·kg-1 body mass sodium chloride
Placebo
0.03 g·kg-1 body mass sodium chloride
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Soidum Bicarbonate
Supplementation with 0.03 g/kg of sodium bicarbonate
Placebo
0.03 g·kg-1 body mass sodium chloride
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Universidad Isabel I
UNKNOWN
Universidad de Burgos
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
MARIA MARTINEZ
Doctor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Universidad de Burgos
Burgos, , Spain
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Bicarbonaterugby
Identifier Type: REGISTRY
Identifier Source: secondary_id
Bicarbonaterugby
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.